Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)

China flag China · Delayed Price · Currency is CNY
16.75
+0.03 (0.18%)
Apr 8, 2026, 3:00 PM CST
Market Cap9.24B -23.1%
Revenue (ttm)10.50B -15.2%
Net Income120.57M +352.4%
EPS0.22 +340.0%
Shares Out551.42M
PE Ratio76.14
Forward PE10.92
Dividendn/a
Ex-Dividend Daten/a
Volume9,896,600
Average Volume7,216,160
Open16.81
Previous Close16.72
Day's Range16.64 - 16.95
52-Week Range15.09 - 25.51
Beta0.45
RSI50.74
Earnings DateMar 28, 2026

About SHA:600129

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, produces, and sells Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Commercial; Chinese Herbal Medicine Resources; and Service Industry and Others segments. The company offers digestive system and metabolic, respiratory system, cardiovascular and cerebrovascular, anti-infective, nervous system, and anti-tumor and immunomodulatory drugs; anti-aging; and health products. It also engages in accomm... [Read more]

Sector Healthcare
Founded 1979
Employees 11,971
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600129
Full Company Profile

Financial Performance

In 2025, SHA:600129's revenue was 10.50 billion, a decrease of -15.23% compared to the previous year's 12.39 billion. Earnings were 120.57 million, an increase of 352.37%.

Financial Statements